NCT03051321

Brief Summary

The inability to independently manage perineal hygiene after toileting is a common issue for those in assisted living and nursing home environments. It is associated with skin breakdown (dermatitis), increased nursing costs, and loss of patient self-esteem and independence. Water-based toileting has been evaluated as a possible adjunct to patient care, but its uptake has been limited by ineffective cleansing and drying. 40 subjects with limitations in independent capacity for perineal hygiene that require assistance with toileting will be recruited from a continued care retirement center. Subjects will be assessed for incontinence, and skin breakdown or irritation. Subjects will be provided a Wellness Toilet System, cleanser, and, if needed, zinc oxide barrier spray to be applied in cases of dermatitis. Investigators hypothesize that subjects given the device will remain more independent, with higher quality of life. Secondary hypotheses are that subjects will experience improved relationships with their caregivers, and that active dermatitis will be treated in those already with the condition, and prevented in those at risk.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 7, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 13, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

May 30, 2018

Status Verified

May 1, 2018

Enrollment Period

1.2 years

First QC Date

February 7, 2017

Last Update Submit

May 29, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Days Remaining in independent living environment

    Subject does not require assistance for perineal hygiene that requires change of living environment

    24 weeks

Secondary Outcomes (2)

  • Improved quality of life

    24 weeks

  • Treatment and prevention of incontinence associated dermatitis

    24 weeks

Study Arms (1)

Wellness toileting system

EXPERIMENTAL

Subjects given SchwabCare Wellness Toileting system

Device: Wellness toilet system

Interventions

Water-based toileting with capacity to apply zinc oxide barrier spray to treat incontinence associated dermatitis

Also known as: SchwabCare Wellness Toileting System
Wellness toileting system

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Limitation of Activity of Daily Living - Toileting, requiring assistance, beginning stages of unmanaged incontinence. For the purposes of this study, toileting refers to maintenance of hygiene and ability to clean the perineum after urination or defecation. It does not include inability to transfer to a commode only.

You may not qualify if:

  • Inability to obtain consent
  • Weight over 300 pounds
  • Prior pelvic radiation
  • Pelvic Floor surgery within the 6 weeks prior to enrollment
  • Active perineal infection
  • Active chemotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Canterbury

Rancho Palos Verdes, California, 90275, United States

RECRUITING

The Village at Marymount

Garfield Heights, Ohio, 44125, United States

RECRUITING

MeSH Terms

Conditions

Dermatitis

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Richard S Tilson, MD MPH

    Director of Clinical Investigation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jacqueline Silvia

CONTACT

Richard s Tilson, MD MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2017

First Posted

February 13, 2017

Study Start

April 1, 2017

Primary Completion

June 1, 2018

Study Completion

October 1, 2018

Last Updated

May 30, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations